SELLAS Life Sciences Provides Business Update and Reports First Quarter 2019 Financial Results

NEXT STORY
ADMA Biologics Announces Proposed $45 Million Public Offering of Common Stock
PREV STORY
Agios to Present Clinical Data from its IDH Program at ASCO
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Heat Biologics and University of Miami Announce Zika Vaccine Collaboration

New Infectious Disease Subsidiary to Apply Heat’s Proprietary Platform Technology to Zika Virus and ...

author_avatar
NASDAQ Market News

Flexion Therapeutics Highlights Two Clinical Data Presentations at the Osteoarthritis Research Society International 2017 World Congress

In an analysis of pooled Phase 2/3 data, ZilrettaTM (FX006) demonstrated clinically meaningful pain ...

author_avatar
NASDAQ Market News

Sunesis Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference

SOUTH SAN FRANCISCO, Calif., March 28, 2017 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

author_avatar
NASDAQ Market News